Search

everythinglearnresearchcommunity

for

Search:↓

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Treating stubborn hair loss involves both medical and emotional support options.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Regenerative medicine is effective and safe for treating vitiligo.

Misinformation about alopecia can lead to poor treatment, so it's important for healthcare professionals to correct myths.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Misinformation about alopecia is common online and can harm patient choices.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Alopecia areata significantly impacts patients' mental health and quality of life.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Tretinoin alone is more effective than combined with microdermabrasion for long-term alopecia areata treatment.

Oral tofacitinib successfully treated total body hair loss in one patient.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Skin aging is a complex process influenced by various factors, leading to wrinkles and sagging, and should be considered a disease due to its health impacts.